Gleevec does not cross blood-brain barrier.
Senior
Kathryn
K
D000818:Animals; D000970:Antineoplastic Agents / Q000493:pharmacokinetics*; D001549:Benzamides; D001812:Blood-Brain Barrier; D006801:Humans; D000068877:Imatinib Mesylate; D051379:Mice; D010879:Piperazines / Q000493:pharmacokinetics*; D011505:Protein-Tyrosine Kinases / Q000032:analysis; D011743:Pyrimidines / Q000493:pharmacokinetics*
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D011505:Protein-Tyrosine Kinases